Metraipolis › archive › dc_e952d70cf797

Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42187563
DOI
10.3390/curroncol33050246
License (as archived)
solo-consultazione
Archived
2026-10-08T04:50:54.185Z
SHA-256 of the archived text
8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350
Stable URL of this page
https://metraipolis.com/documento/dc_e952d70cf797

How to cite

Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563 — Europe PMC (en), https://europepmc.org/article/MED/42187563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e952d70cf797 (Metraipolis archive dc_e952d70cf797, sha256 8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350)
BibTeX
@misc{dce952d70cf797,
  title = {Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42187563},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e952d70cf797; sha256 8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42187563. Agents can read the archived copy with the MCP tool read_document.